StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
SUCROSA.BO$9.95+0.10%
Fair $9.95+0.0%

SUCROSA.BO

Super Crop Safe Limited

Basic Materials / Agricultural InputsBSE

$9.95

+0.01 (+0.10%)

Fairly Valued+0.0%Fair Value $9.95Fund rank 20/100 · Data gapFallback financials|
SA 40/C
F-Score: 4/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 14%

FCF escenarios

weak_data · normalized FCF $-30.8M · quality 25.7/100

Data gap 20/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 8/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

40/100

C

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists.
Thesis & Journal · SUCROSA.BOLocal privado en este navegador · Super Crop Safe Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$400M

P/E

24.9x

↑

EV/EBITDA

19.4x

↑

ROE

7.4%

↑

Gross Margin

21.6%

↑

Debt/Equity

1.47

↑
52-Week Range$10
$7$15

TradingView lightweight chart

SUCROSA.BO price, volumen y niveles de valoración

Último $9.950Periodo +397.5%
Fair value: $9.950

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+31.4%

FCF CAGR

—

FCF margin

-6.8%

FCF / Net income

-1.42x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $453.9M · net income $21.6M · FCF $-30.8M

2022-FY → 2025-FY

Gross margin

21.6%+13.9% pts

Operating margin

8.4%+34.5% pts

Net margin

4.8%+37.1% pts

FCF margin

-6.8%-8.7% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$453.9M$453.9M$312.5M$225.4M$200.0M
Net Income$21.6M$21.6M$13.3M$10.1M$-64.6M
EBITDA$42.7M$42.7M$39.1M$32.7M$-42.9M
EPS0.540.540.330.25-1.61
Gross Margin21.6%21.6%29.4%39.0%7.7%
Operating Margin8.4%8.4%10.9%11.7%-26.0%
Net Margin4.8%4.8%4.3%4.5%-32.3%
Balance Sheet
Debt/Equity1.471.471.460.660.69
Cash Flow
Free Cash Flow$-30.8M$-30.8M$-187.1M$13.3M$3.7M
Returns
ROE7.4%7.4%4.9%3.9%-26.1%
Valuation
P/E24.8824.8848.2322.36—
EV/EBITDA19.4219.4226.5412.08—
P/B1.371.372.370.871.11
Growth & Yield
Revenue Growth45.3%45.3%38.6%12.7%—
EPS Growth62.5%62.5%32.4%115.6%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

17.9%

exigente

EPS terminal req.

$0.88

Spread vs growth

44.6%

5Y implied EPS CAGR

14.7%

razonable

EPS terminal req.

$1.07

Spread vs growth

47.8%

10Y implied EPS CAGR

12.3%

razonable

EPS terminal req.

$1.72

Spread vs growth

50.2%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -33.0%

Total return

-33.0%

Start / end P/E

44.9x → 18.5x

EPS bridge

0.33 → 0.54

Residual

-36.7%

EPS growth+62.5%
Multiple rerating-58.8%
Dividend+0.0%
Residual / FX / buybacks / cross-term-36.7%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.